Report post

What does bioarctic do?

BioArctic also engages in disease modifying treatments and diagnostics for neurodegenerative diseases such as Alzheimer's and Parkinson's diseases. BioArctic serves patients in Sweden. Stock analysis for BioArctic AB (BIOAB:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Where is bioarctic AB Series B headquartered?

The company was founded by Lars Gunnar Lannfelt and Pär Lars Gellerfors on January 24, 2003 and is headquartered in Stockholm, Sweden. BIOA.B | Complete BioArctic AB Series B stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

What is bioarctic AB?

BioArctic AB (publ) develops biological drugs for patients with disorders of the central nervous system in Sweden. The company develops Lecanemab, Lecanemab AHEAD 3-45, and Lecanemab Back-up for the treatment of Alzheimer's disease.

The World's Leading Crypto Trading Platform

Get my welcome gifts